Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.
Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, College of Life Sciences, University of California at Los Angeles, Los Angeles, CA 90095; and
J Immunol. 2019 Apr 1;202(7):1927-1933. doi: 10.4049/jimmunol.1801403.
Epidemiologic data demonstrate sex differences in autoimmune diseases, immune responses against infection, and antitumor immunity, and accumulating evidence suggests a major role for sex hormones in mediating these differences. In this study, we review recent advances in understanding how sex hormones regulate T cell responses to alter susceptibility to autoimmunity. Although sex hormones can directly alter gene transcriptional programs of T cells, we focus in this study on how sex hormones alter T cell development and function through their effects on thymic stromal cells and innate cell types. In addition to contributing to our understanding of sex differences, these findings also have implications for the therapeutic use of sex hormones and sex hormone modulators, which are now being prescribed to increasing numbers of patients for a wide variety of indications.
流行病学数据表明,性别差异存在于自身免疫性疾病、抗感染免疫反应和抗肿瘤免疫中,越来越多的证据表明性激素在调节这些差异方面起着重要作用。在这项研究中,我们回顾了近年来关于性激素如何调节 T 细胞反应从而改变自身免疫易感性的研究进展。尽管性激素可以直接改变 T 细胞的基因转录程序,但我们在本研究中主要关注性激素如何通过对胸腺基质细胞和固有细胞类型的影响来改变 T 细胞的发育和功能。这些发现除了有助于我们理解性别差异外,还对性激素和性激素调节剂的治疗应用具有重要意义,现在越来越多的患者出于各种适应证正在接受这些药物的治疗。